Multicentre clinical evaluation of the new highly sensitive Elecsys® thyroglobulin II assay in patients with differentiated thyroid carcinoma.
Pierpaolo TrimboliM ImperialiA PiccardoAlfredo CampenníI GiordaniR M RuggeriS BaldariF OrlandiL GiovanellaPublished in: Clinical endocrinology (2017)
Using appropriate assay-specific cut-offs, the clinical performance of the Elecsys® Tg II assay was comparable to that provided by the well-established Access® Tg assay.